Results 141 to 150 of about 5,707,439 (181)

The Mechanism of Tigecycline Resistance in Acinetobacter baumannii Revealed by Proteomic and Genomic Analysis

open access: yesInternational Journal of Molecular Sciences, 2023
The mechanism of tigecycline resistance in A. baumannii remains largely unclear. In this study, we selected a tigecycline-resistant and a tigecycline-susceptible strain from a tigecycline-susceptible and a resistant strain, respectively.
Di Xiao, Qinghua Zou
exaly   +3 more sources

The emergence of clinical resistance to tigecycline

International Journal of Antimicrobial Agents, 2013
Tigecycline (TIG) exhibits broad-spectrum activity against many Gram-positive and Gram-negative pathogens. However, clinical resistance has emerged recently and has been detected following treatment with TIG. This observation suggests that long-term monotherapy may carry a high risk for TIG resistance.
Yun Cai, Rui Wang, Xu Liu
exaly   +3 more sources

RshA mutations contributing to tigecycline resistance in Mycobacteroides abscessus

Journal of Medical Microbiology, 2022
Tigecycline is an important rescue antibiotic for many bacterial infections. In Mycobacteroides abscessus , tigecycline resistance has been associated with dysregulated stress response caused by aberrations in the interaction of the SigH and RshA factors.
Kar Men Aw   +4 more
openaire   +3 more sources

A Potential Nontraditional Approach To Combat tmexCD1-toprJ1- Mediated Tigecycline Resistance: Melatonin as a Synergistic Adjuvant of Tigecycline

open access: yesAntimicrobial Agents and Chemotherapy, 2023
The emergence of TMexCD1-TOprJ1, a novel transferable resistance-nodulation-division (RND)-type efflux pump conferring resistance to tigecycline, is now a serious public health issue in the world.
Jinhu Huang   +2 more
exaly   +2 more sources

Mechanisms of tigecycline resistance in Gram-negative bacteria: A narrative review

open access: yesEngineering Microbiology
Tigecycline serves as a critical "final-resort" antibiotic for treating bacterial infections caused by multidrug-resistant bacteria for which treatment options are severely limited.
Hai Xu, Xiuhua Pang, Chengzhang Fu
exaly   +2 more sources

Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review [PDF]

open access: yesEuropean Journal of Clinical Microbiology and Infectious Diseases, 2021
Tigecycline is unique glycylcycline class of semisynthetic antimicrobial agents developed for the treatment of polymicrobial infections caused by multidrug-resistant Gram-positive and Gram-negative pathogens.
Farajolah Maleki   +2 more
exaly   +2 more sources

Curcumin reverses high-level tigecycline resistance mediated by different mechanisms in Gram-negative bacteria

Phytomedicine
BACKGROUND Tigecycline is one of the few effective treatments for multidrug-resistant bacteria. However, the recent emergence and spread of high-level tigecycline resistance in Enterobacteriaceae have significantly limited its clinical use.
Yajun Zhai
exaly   +2 more sources

Emergence of high-level tigecycline resistance due to the amplification of a tet(A) gene variant in clinical carbapenem-resistant Klebsiella pneumoniae.

Clinical Microbiology and Infection, 2023
OBJECTIVE To investigate the prevalence of a tet(A) gene variant and its role in developing high-level tigecycline resistance among carbapenem-resistant Klebsiella pneumoniae (CRKP) clinical isolates.
Runhao Yu   +8 more
semanticscholar   +1 more source

The tigecycline resistance gene tetX has an expensive fitness cost based on increased outer membrane permeability and metabolic burden in Escherichia coli.

Journal of Hazardous Materials, 2023
Livestock-derived tetX-positive Escherichia coli with tigecycline resistance poses a serious risk to public health. Fitness costs, antibiotic residues, and other tetracycline resistance genes (TRGs) are fundamental in determining the spread of tetX in ...
Tao Chen   +12 more
semanticscholar   +1 more source

Characterization of a Novel Tigecycline Resistance Gene tet(X22) and its Coexistence with blaNDM-1 in a Pseudomonas caeni Isolate.

International Journal of Antimicrobial Agents, 2023
The emergence of pathogens resistant to both tigecycline and carbapenem poses a threat to public health globally. Continuous emergence of novel tet(X) variants accelerates the tigecycline resistance crisis.
Xiaoyu Lu   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy